Evidence map›Paper›PMID 39547802›Full record

ArticleAJNR. American journal of neuroradiology2025

Deep Learning-Based Algorithm for Automatic Quantification of Nigrosome-1 and Parkinsonism Classification Using Susceptibility Map-Weighted MRI.

Pae Sun Suh, Hwan Heo, Chong Hyun Suh, MyeongOh Lee, Soohwa Song, Donghoon Shin, Sungyang Jo, Sun Ju Chung, Hwon Heo, Woo Hyun Shim and 3 more

Abstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. The combination of theScientific reports · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Pae Sun SuhFrom the Department of Radiology and Research Institute of Radiology (P.S.S., C.H.S. Hwon Heo, W.H.S., H.S.K., S.J.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.ORCID 0000-0002-8618-9558
Hwan HeoHeuron Co. Ltd. (Hwan Heo, M.L., S.S., D.S.), Seoul, Republic of Korea.ORCID 0000-0003-2144-6637
Chong Hyun SuhFrom the Department of Radiology and Research Institute of Radiology (P.S.S., C.H.S. Hwon Heo, W.H.S., H.S.K., S.J.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea chonghyunsuh@amc.seoul.kr.ORCID 0000-0002-4737-0530
MyeongOh LeeHeuron Co. Ltd. (Hwan Heo, M.L., S.S., D.S.), Seoul, Republic of Korea.
Soohwa SongHeuron Co. Ltd. (Hwan Heo, M.L., S.S., D.S.), Seoul, Republic of Korea.ORCID 0000-0002-4723-5603
Donghoon ShinHeuron Co. Ltd. (Hwan Heo, M.L., S.S., D.S.), Seoul, Republic of Korea.
Sungyang JoDepartment of Neurology (S.J., S.J.C.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.ORCID 0000-0001-5097-2340
Sun Ju ChungDepartment of Neurology (S.J., S.J.C.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Hwon HeoFrom the Department of Radiology and Research Institute of Radiology (P.S.S., C.H.S. Hwon Heo, W.H.S., H.S.K., S.J.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.ORCID 0000-0002-6103-4680
Woo Hyun ShimFrom the Department of Radiology and Research Institute of Radiology (P.S.S., C.H.S. Hwon Heo, W.H.S., H.S.K., S.J.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.ORCID 0000-0002-7251-2916
Ho Sung KimFrom the Department of Radiology and Research Institute of Radiology (P.S.S., C.H.S. Hwon Heo, W.H.S., H.S.K., S.J.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.ORCID 0000-0002-9477-7421
Sang Joon KimFrom the Department of Radiology and Research Institute of Radiology (P.S.S., C.H.S. Hwon Heo, W.H.S., H.S.K., S.J.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.ORCID 0000-0001-7070-7333
Eung Yeop KimDepartment of Radiology (E.Y.K.), Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.ORCID 0000-0002-9579-4098

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeThe diagnostic performance of deep learning model that simultaneously detecting and quantifying nigrosome-1 abnormality by using susceptibility map-weighted imaging (SMwI) remains unexplored. This study aimed to develop and validate a deep learning-based automatic quantification for nigral hyperintensity and a classification algorithm for neurodegenerative parkinsonism. MATERIALS AND

methodsWe retrospectively collected 450 participants (210 with idiopathic Parkinson disease [IPD] and 240 individuals in the control group) for training data between November 2022 and May 2023, and 237 participants (168 with IPD, 58 with essential tremor, and 11 with drug-induced parkinsonism) for validation data between July 2021 and January 2022. SMwI data were reconstructed from multiecho gradient echo. Diagnostic performance for diagnosing IPD was assessed by using deep learning-based automatic quantification (Heuron NI) and classification (Heuron IPD) models. Reference standard for IPD was based on N-3-fluoropropyl-2-β-carbomethoxy-3-β-(4-iodophenyl) nortropane PET finding. Additionally, the correlation between the Hoehn and Yahr (H&Y) stage and volume of nigral hyperintensity in patients with IPD was assessed.

resultsQuantification of nigral hyperintensity by using Heuron NI showed an area under the curve (AUC) of 0.915 (95% CI, 0.872-0.947) and 0.928 (95% CI, 0.887-0.957) on the left and right, respectively. Classification of nigral hyperintensity abnormality by using Heuron IPD showed area under the curve of 0.967 (95% CI, 0.936-0.986) and 0.976 (95% CI, 0.948-0.992) on the left and right, respectively. H&Y score ≥3 showed smaller nigral hyperintensity volume (1.43 ± 1.19 mm

conclusionsOur deep learning-based model proves rapid, accurate automatic quantification of nigral hyperintensity, facilitating IPD diagnosis, symptom severity prediction, and patient stratification for personalized therapy. Further study is warranted to validate the findings across various clinical settings.

Indexed as

Deep LearningMagnetic Resonance ImagingParkinson DiseaseParkinsonian DisordersSubstantia NigraAgedAlgorithmsFemaleHumansImage Interpretation, Computer-AssistedMaleMiddle AgedRetrospective Studies

Identifiers

PMID39547802
PMCPMC12091983

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.